Literature DB >> 19494277

Direct stimulation of tlr5+/+ CD11c+ cells is necessary for the adjuvant activity of flagellin.

John T Bates1, Satoshi Uematsu, Shizuo Akira, Steven B Mizel.   

Abstract

Flagellin is a highly effective adjuvant, but the cellular mechanism underlying this activity remains uncertain. More specifically, no consensus exists as to whether flagellin activates dendritic cells (DC) directly or indirectly. Intramuscular immunization with flagellin-OVA fusion protein resulted in enhanced in vivo T cell clustering in draining lymph nodes and IL-2 production by OVA-specific CD4(+) T cells. Immunization with flagellin-OVA also triggered greater levels of Ag-specific CD4(+) T cell proliferation than immunization with flagellin and OVA as separate proteins. To determine whether flagellin, in the context of a fusion protein with OVA, was acting directly on DC, we used a combination of CD4(+) T cell adoptive transfers and bone marrow chimera mice in which the presence or absence of potential tlr5(+/+) CD11c(+) cells was controlled by injection of diphtheria toxin. The Ag-specific CD4(+) T cell response in mice with CD11c(+) cells from a tlr5(-/-) background and mixed populations of all other hematopoietic cells was dramatically reduced in comparison to mice that had DC from tlr5(-/-) and wild-type backgrounds. Immunization of MyD88(-/-)tlr5(+/+) mice revealed that the enhanced response following immunization with flagellin-OVA is dependent on signaling via the TLR5-MyD88 pathway as well as enhanced Ag uptake and processing resulting from Ag targeting via TLR5. In summary, our data are consistent with the conclusion that direct stimulation of tlr5(+/+) CD11c(+) cells is necessary for the adjuvant activity of a flagellin fusion protein and that this adjuvant effect requires signaling through TLR5.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19494277      PMCID: PMC3770462          DOI: 10.4049/jimmunol.0804225

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Visualizing T cell competition for peptide/MHC complexes: a specific mechanism to minimize the effect of precursor frequency.

Authors:  A L Smith; M E Wikstrom; B Fazekas de St Groth
Journal:  Immunity       Date:  2000-12       Impact factor: 31.745

2.  Toll-like receptor ligand activation of murine bone marrow-derived dendritic cells.

Authors:  Rebecca J Dearman; Marie Cumberbatch; Gavin Maxwell; David A Basketter; Ian Kimber
Journal:  Immunology       Date:  2008-09-04       Impact factor: 7.397

3.  Mucosal adjuvant activity of flagellin in aged mice.

Authors:  John T Bates; Anna N Honko; Aaron H Graff; Nancy D Kock; Steven B Mizel
Journal:  Mech Ageing Dev       Date:  2008-02-17       Impact factor: 5.432

4.  High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation.

Authors:  P F McDermott; F Ciacci-Woolwine; J A Snipes; S B Mizel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens.

Authors:  Evan F Lind; Cory L Ahonen; Anna Wasiuk; Yoko Kosaka; Burkhard Becher; Kathy A Bennett; Randolph J Noelle
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

6.  Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.

Authors:  Steven B Mizel; Aaron H Graff; Nammalwar Sriranganathan; Sean Ervin; Cynthia J Lees; Mark O Lively; Roy R Hantgan; Michael J Thomas; James Wood; Brian Bell
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

7.  Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function.

Authors:  Subhashini Arimilli; John B Johnson; Kimberly M Clark; Aaron H Graff; Martha A Alexander-Miller; Steven B Mizel; Griffith D Parks
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

8.  Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice.

Authors:  J McEwen; R Levi; R J Horwitz; R Arnon
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction.

Authors:  Ok S Shin; Ralph R Isberg; Shizuo Akira; Satoshi Uematsu; Aruna K Behera; Linden T Hu
Journal:  Infect Immun       Date:  2008-03-31       Impact factor: 3.441

10.  Induction of adaptive immunity by flagellin does not require robust activation of innate immunity.

Authors:  Catherine J Sanders; Luigi Franchi; Felix Yarovinsky; Satoshi Uematsu; Shizuo Akira; Gabriel Núñez; Andrew T Gewirtz
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

View more
  35 in total

1.  Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88.

Authors:  John T Bates; Aaron H Graff; James P Phipps; Jason M Grayson; Steven B Mizel
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

2.  A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice.

Authors:  Kristen N Delaney; James P Phipps; John B Johnson; Steven B Mizel
Journal:  Viral Immunol       Date:  2010-04       Impact factor: 2.257

Review 3.  Use of defined TLR ligands as adjuvants within human vaccines.

Authors:  Malcolm S Duthie; Hillarie Plessner Windish; Christopher B Fox; Steven G Reed
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

4.  TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity.

Authors:  Shirdi E Letran; Seung-Joo Lee; Shaikh M Atif; Satoshi Uematsu; Shizuo Akira; Stephen J McSorley
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

Review 5.  Flagellin as an adjuvant: cellular mechanisms and potential.

Authors:  Steven B Mizel; John T Bates
Journal:  J Immunol       Date:  2010-11-15       Impact factor: 5.422

6.  Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway.

Authors:  Américo Harry López-Yglesias; Xiaodan Zhao; Ellen K Quarles; Marvin A Lai; Tim VandenBos; Roland K Strong; Kelly D Smith
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

7.  An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates.

Authors:  Beth C Holbrook; S Tyler Aycock; Emily Machiele; Elene Clemens; Danielle Gries; Matthew J Jorgensen; Mallinath B Hadimani; S Bruce King; Martha A Alexander-Miller
Journal:  Immunology       Date:  2017-10-24       Impact factor: 7.397

8.  Protective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.

Authors:  Daniel Carapau; Robert Mitchell; Adéla Nacer; Alan Shaw; Caroline Othoro; Ute Frevert; Elizabeth Nardin
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

9.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

10.  Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.

Authors:  Jason R Smedberg; Marlena M Westcott; Maryam Ahmed; Douglas S Lyles
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.